midostaurin

midostaurin
Trade Name Rydapt
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2009-07-07 00:00:00
Sponsor Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936